tiprankstipranks
Trending News
More News >
Cadrenal Therapeutics CMO Douglas Losordo departs, James Ferguson succeeds
PremiumThe FlyCadrenal Therapeutics CMO Douglas Losordo departs, James Ferguson succeeds
4M ago
Cadrenal Therapeutics to initiate Phase 3 clinical trial for tecarfarin in 2025
Premium
The Fly
Cadrenal Therapeutics to initiate Phase 3 clinical trial for tecarfarin in 2025
5M ago
Cadrenal Therapeutics files to sell 590K shares of common stock for holders
Premium
The Fly
Cadrenal Therapeutics files to sell 590K shares of common stock for holders
6M ago
Cadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy
PremiumCompany AnnouncementsCadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy
8M ago
Cadrenal Therapeutics to discuss tecarfarin trial with FDA in September
Premium
The Fly
Cadrenal Therapeutics to discuss tecarfarin trial with FDA in September
9M ago
Cadrenal Therapeutics Inc trading resumes
Premium
The Fly
Cadrenal Therapeutics Inc trading resumes
9M ago
Cadrenal Therapeutics Enhances Incentives and Adjusts Stock Plan
PremiumCompany AnnouncementsCadrenal Therapeutics Enhances Incentives and Adjusts Stock Plan
10M ago
Cadrenal Therapeutics highlights data on ARIES-HM3 trial at ISHLT
Premium
The Fly
Cadrenal Therapeutics highlights data on ARIES-HM3 trial at ISHLT
12M ago
Cadrenal Therapeutics Gains FDA Orphan Drug Status for Tecarfarin
Premium
Company Announcements
Cadrenal Therapeutics Gains FDA Orphan Drug Status for Tecarfarin
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100